Core Viewpoint - BMO Capital has raised the price target for ManpowerGroup (MAN) to $45 from $44 while maintaining an Outperform rating on the shares, indicating positive sentiment towards the company's performance and future prospects [1]. Financial Performance - ManpowerGroup's Q4 results slightly exceeded consensus estimates, benefiting from a weaker USD, which positively impacted revenue [1]. - Constant currency growth showed a modest acceleration, suggesting underlying strength in the company's operations despite external currency fluctuations [1]. Business Segments - The enterprise staffing and blue-collar assignments segments are performing well, indicating strong demand in these areas [1]. - In contrast, the permanent placement and Recruitment Process Outsourcing (RPO) segments continue to face challenges, highlighting a mixed performance across different business lines [1].

Group 1 - Evercore ISI raised the price target on Labcorp (LH) to $305 from $300 while maintaining an Outperform rating on the shares [1] - The firm's survey indicates a positive outlook for preclinical CROs, with rising budgets and declining cancellations [1] - There is stable demand for discovery and toxicology services projected into 2025 and 2026 [1]